Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2651-2026

IQon Spectral CT IQon Spectral CT Upgrades Recall

IQon Spectral CT IQon Spectral CT Upgrades

FDA recall Class II

Ongoing

FDA lists this Class II recall for IQon Spectral CT IQon Spectral CT Upgrades. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2651-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Jun 11, 2026
FDA report date
Aug 5, 2026
Quantity in commerce
42
Distribution
See key details
FDA cause
Radiation Control for Health and Safety Act

What is being recalled?

IQon Spectral CT IQon Spectral CT Upgrades

The retrieved code information does not contain explicit model/GTIN pairs that this publication can reliably map.

Search FDA identifier text

Search a model, catalog, lot or UDI value exactly as printed in FDA’s product description or code information.

This search checks only the FDA product description and code information displayed on this page. It does not decode a UDI, normalize GTIN lengths or establish a relationship between separately listed codes.

FDA code information

FCO72800812; FCO72800814 728331 728332, DI (01)00884838059542

View the original FDA recall notice

Why was this product recalled?

The clinical CT scan may not automatically trigger after the Bolus Tracking scan and may need to be triggered manually. Additional Bolus Tracking shots may occur. This may result in the clinical acquisition being inadequate for diagnosis, causing a potential for patient rescan and receiving additional radiation.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did PHILIPS MEDICAL SYSTEMS take?

An Electronic Product Radiation Correction letter was issued to its customers describing the product, problem and actions to be taken by its customers. To identify the software version of your product: 1. Click the Help button. 2. Select About and the software version is then displayed. The software version begins with v. 3.You may continue to use your system(s) in accordance with the intended use. 4. Please complete and return the attached response form to Philips promptly and no later than 30 days from receipt. Completing this form confirms receipt of the Electronic Product Radiation Correction Letter, understanding of the issues, and required actions to be taken. 5. Circulate this Electronic Product Radiation Correction Letter to all users of this device so that they are aware of the issues. Please retain this letter with your system(s) until a solution is installed on your system; ensure the letter is in a place likely to be seen/viewed. Actions planned by Philips to correct the problem Philips will contact you to schedule a time for a Philips Field Service Engineer (FSE) to visit your site and install the software update to resolve the issues. If you need any further information or support concerning this issue, please contact your local Philips representative: For North America, contact the Customer Care Solutions Center (1-800-722-9377).

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology